ABT-594 improves performance in the 5-choice serial reaction time task under conditions of increased difficulty, sub-chronic dosing, and in poorly-performing subjects

Pharmacology Biochemistry and Behavior

Volumn 95, Issue 2, 2010, Pages 146-157

  Mohler, Eric G ^a   Franklin, Stanley R ^a   Rueter, Lynne E ^a   Fox, Gerard B ^a   Decker, Michael W ^a   Browman, Kaitlin E ^a  

^a ABBOTT LABORATORIES   (United States)

Author keywords

4 2; 5 Choice serial reaction time task; Acetylcholine; Attention; Nicotine

Indexed keywords

5 (2 AZETIDINYLMETHOXY) 2 CHLOROPYRIDINE;

ACUTE DRUG ADMINISTRATION; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; ATTENTION; CHRONIC DRUG ADMINISTRATION; CONTROLLED STUDY; DOSE RESPONSE; DRUG ACTIVITY; DRUG DOSE COMPARISON; MALE; MENTAL PERFORMANCE; MENTAL TASK; NONHUMAN; PRIORITY JOURNAL; RAT; STIMULUS RESPONSE;

ANIMALS; AZETIDINES; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; NICOTINIC AGONISTS; PYRIDINES; RATS; REACTION TIME; RECEPTORS, NICOTINIC;

RATTUS;

EID: 76949102249     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2009.12.019     Document Type: Article

References (40)

1. Allain H., Akwa Y., Lacomblez L., Lieury A., and Bentué-Ferrer D. Impaired cognition and attention in adults: pharmacological management strategies. Neuropsychiatr Dis Treat 3 1 (2007) 103-116
2. Bizarro L., Patel S., Murtagh C., and Stolerman I.P. Differential effects of psychomotor stimulants on attentional performance in rats: nicotine, amphetamine, caffeine and methylphenidate. Behav Pharmacol 15 3 (2004) 195-206
3. Bizarro L., and Stolerman I.P. Attentional effects of nicotine and amphetamine in rats at different levels of motivation. Psychopharm (Berl) 170 3 (2003) 271-277
4. Blondel A., Sanger D.J., and Moser P.C. Characterisation of the effects of nicotine in the five-choice serial reaction time task in rats: antagonist studies. Psychopharm (Berl) 149 3 (2000) 293-305
5. Buccafusco J., Terry Jr. A.V., Decker M.W., and Gopalakrishnan M. Profile of nicotinic acetylcholine receptor agonists ABT-594 and A-582941, with differential subtype selectivity, on delayed matching accuracy by young monkeys. Biochem Pharmacol 74 8 (2007) 1202-1211
6. Bushnell P.J., Oshiro W.M., and Padnos B.K. Detection of visual signals by rats: effects of chlordiazepoxide and cholinergic and adrenergic drugs on sustained attention. Psychopharmacology (Berl) 134 3 (1997) 230-241
7. Carli M., Robbins T.W., Evenden J.L., and Everitt B.J. Effects of lesions to ascending noradrenergic neurons on performance on a 5-choice serial reaction time task in rats: implications for theories of dorsal noradrenergic bundle function based on selective attention and arousal. Behav Brain Res 9 (1983) 361-380
8. Day M., Pan J.B., Buckley M.J., Cronin E., Hollingsworth P.R., Hirst W.D., et al. Differential effects of ciproxifan and nicotine on impulsivity and attention measures in the 5-choice serial reaction time test. Biochem Pharmacol 73 8 (2007) 1123-1134
9. Donnelly-Roberts D.L., Puttfarcken P.S., Kuntzweiler T.A., Briggs C.A., Anderson D.J., Campbell J.E., et al. ABT-594 [(R)-5-(2-azetidinylmethoxy)-2-chloropyridine]: a novel, orally effective analgesic acting via neuronal nicotinic acetylcholine receptors: I. In vitro characterization. J Pharmacol Exp Ther 285 2 (1998) 777-786
10. Foulds J., Stapleton J., Swettenham J., Bell N., McSorley K., and Russell M.A. Cognitive performance effects of subcutaneous nicotine in smokers and never-smokers. Psychopharm (Berl) 127 1 (1996) 31-38
11. Giessing C., Fink G.R., Rösler F., and Thiel C.M. fMRI data predict individual differences of behavioral effects of nicotine: a partial least square analysis. J Cogn Neurosci 19 4 (2007) 658-670
12. Grottick A.J., Haman M., Wyler R., and Higgins G.A. Reversal of a vigilance decrement in the aged rat by subtype-selective nicotinic ligands. Neuropsychopharm 28 5 (2003) 880-887
13. Grottick A.J., and Higgins G.A. Effect of subtype selective nicotinic compounds on attention as assessed by the five-choice serial reaction time task. Behav Brain Res 117 1-2 (2000) 197-208
14. Grottick A.J., and Higgins G.A. Assessing a vigilance decrement in aged rats: effects of pre-feeding, task manipulation, and psychostimulants. Psychopharm (Berl) 164 1 (2002) 33-41
15. Grottick A.J., Wyler R., and Higgins G.A. A study of the nicotinic agonist SIB-1553A on locomotion and attention as measured by the five-choice serial reaction time task. Pharmacol Biochem Behav 70 4 (2001) 505-513
16. Hahn B., Ross T.J., Yang Y., Kim I., Huestis M.A., and Stein E.A. Nicotine enhances visuospatial attention by deactivating areas of the resting brain default network. J Neurosci 27 13 (2007) 3477-3489
17. Hahn B., Sharples C.G., Wonnacott S., Shoaib M., and Stolerman I.P. Attentional effects of nicotinic agonists in rats. Neuropharm 44 8 (2003) 1054-1067
18. Hahn B., Shoaib M., and Stolerman I.P. Nicotine-induced enhancement of attention in the five-choice serial reaction time task: the influence of task demands. Psychopharm (Berl) 162 2 (2002) 129-137
19. Hahn B., and Stolerman I.P. Nicotine-induced attentional enhancement in rats: effects of chronic exposure to nicotine. Neuropsychopharm 27 5 (2002) 712-722
20. Holladay M.W., Wasicak J.T., Lin N.H., He Y., Ryther K.B., Bannon A.W., et al. Identification and initial structure-activity relationships of (R)-5-(2-azetidinylmethoxy)-2-chloropyridine (ABT-594), a potent, orally active, non-opiate analgesic agent acting via neuronal nicotinic acetylcholine receptors. J Med Chem 41 4 (1998) 407-412
21. Jensen A.A., Frølund B., Liljefors T., and Krogsgaard-Larsen P. Neuronal nicotinic acetylcholine receptors: structural revelations, target identifications, and therapeutic inspirations. J Med Chem 48 15 (2005) 4705-4755
22. Jones G.M.M., Sahakian B.J., Levy R., Warburton D.M., and Gray J.A. Effects of acute subcutaneous nicotine on attention, information processing and short-term memory in Alzheimer's disease. Psychopharmacology 108 (1992) 485-494
23. Levin E.D., Conners C.K., Silva D., Hinton S.C., Meck W.H., March J., et al. Transdermal nicotine effects on attention. Psychopharm (Berl) 140 2 (1998) 135-141 80
24. Levin E.D., Conners C.K., Sparrow E., Hinton S.C., Erhardt D., Meck W.H., et al. Nicotine effects on adults with attention-deficit/hyperactivity disorder. Psychopharmacology 123 1 (1996) 55-63
25. McGaughy J., Decker M.W., and Sarter M. Enhancement of sustained attention performance by the nicotinic acetylcholine receptor agonist ABT-418 in intact but not basal forebrain-lesioned rats. Psychopharmacology 144 2 (1999) 175-182
26. McGaughy J., and Sarter M. Behavioral vigilance in rats: task validation and effects of age, amphetamine, and benzodiazepine receptor ligands. Psychopharmacology 117 3 (1995) 340-357
27. Mirza N.R., and Bright J.L. Nicotine-induced enhancements in the five-choice serial reaction time task in rats are strain-dependent. Psychopharm (Berl) 154 (2001) 8-12
28. Mirza N.R., and Stolerman I.P. Nicotine enhances sustained attention in the rat under specific task conditions. Psychopharm (Berl) 138 3-4 (1998) 266-274
29. Newhouse P.A., Potter A., and Singh A. Effects of nicotinic stimulation on cognitive performance. Curr Opin Pharmacol 4 (2004) 36-46
30. Rezvani A.H., Bushnell P.J., and Levin E.D. Effects of nicotine and mecamylamine on choice accuracy in an operant visual signal detection task in female rats. Psychopharmacology 164 4 (2002) 369-375
31. Rezvani A.H., Kholdebarin E., Brucato F.H., Callahan P.M., Lowe D.A., and Levin E.D. Effect of R3487/MEM3454, a novel nicotinic alpha7 receptor partial agonist and 5-HT3 antagonist on sustained attention in rats. Prog Neuropsychopharmacol Biol Psychiatry 33 2 (2009) 269-275
32. Rezvani A.H., and Levin E.D. Cognitive effects of nicotine. Biol Psychiatry 49 3 (2001) 258-267
33. Rezvani A.H., and Levin E.D. Nicotinic-glutamatergic interactions and attentional performance on an operant visual signal detection task in female rats. Eur J Pharmacol 465 1-2 (2003) 83-90
34. Rezvani A.H., Tizabi Y., Getachew B., Hauser S.R., Caldwell D.P., Hunter C., et al. Chronic nicotine and dizocilpine effects on nicotinic and NMDA glutamatergic receptor regulation: interactions with clozapine actions and attentional performance in rats. Prog Neuropsychopharmacol Biol Psychiatry 32 4 (2008) 1030-1040
35. Semenova S., Stolerman I.P., and Markou A. Chronic nicotine administration improves attention while nicotine withdrawal induces performance deficits in the 5-choice serial reaction time task in rats. Pharmacol Biochem Behav 87 3 (2007) 360-368
36. Stolerman I.P., Mirza N.R., Hahn B., and Shoaib M. Nicotine in an animal model of attention. Eur J Pharmacol 393 1-3 (2000) 147-154
37. Taly A., Corringer P.J., Guedin D., Lestage P., and Changeux J.P. Nicotinic receptors: allosteric transitions and therapeutic targets in the nervous system. Nat Rev Drug Discov 8 9 (2009) 733-750
38. Turchi J., Holley L.A., and Sarter M. Effects of nicotinic acetylcholine receptor ligands on behavioral vigilance in rats. Psychopharmacology 118 2 (1995) 195-205
39. White H.K., and Levin E.D. Four-week nicotine skin patch treatment effects on cognitive performance in Alzheimer's disease. Psychopharmacology 143 2 (1999) 158-165
40. Young J.W., Finlayson K., Spratt C., Marston H.M., Crawford N., Kelly J.S., et al. Nicotine improves sustained attention in mice: evidence for involvement of the alpha7 nicotinic acetylcholine receptor. Neuropsychopharmacology 29 5 (2004) 891-900